Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Many Bright Ideas Technologies Inc V.MBI.H

Alternate Symbol(s):  MBGNF

Healthcare Biotechnology
Many Bright Ideas Technologies Inc. is a Canada-based company. The Company is focused on commercializing alternative non-medical technologies. It has not generated any revenue.

Recent & Breaking News (TSXV:MBI.H)

Med Biogene Inc. Enters Into Settlement Agreement With Helomics Corporation

MarketWire Canada November 28, 2016

Med BioGene Inc. Announces Commercialization Status of GeneFX Lung(R)

Marketwired December 15, 2015

Med BioGene Inc.: Grant of Stock Options

Marketwired November 19, 2015

Med BioGene Provides Update

Marketwired June 1, 2015

MBI Appointment of Investor Relations and Business Advisory Consultant and Grant of Stock Options

Marketwired May 20, 2015

Appointment of New Director

Marketwired March 2, 2015

MBI Closes Shares for Debt Transaction

Marketwired February 17, 2015

MBI Provides Shareholder Update

Marketwired February 3, 2015

Med BioGene Announces Receipt of Proxies for Upcoming Annual and Special Meeting

Marketwired September 4, 2014

Med BioGene Reports Financial Results for Q2 2014

Marketwired August 29, 2014

Med BioGene Responds to Assertions Made by Dissident Shareholder

Marketwired August 21, 2014

Med BioGene Provides Update and Announces Proposed Financing

Marketwired August 15, 2014

Med BioGene Announces Director Nominations and Postponement of Annual and Special Meeting

Marketwired August 6, 2014

Med Biogene Reports Financial Results for Q1 2014

Marketwired May 30, 2014

Med BioGene Reports Financial Results for 2013

Marketwired April 30, 2014

Med BioGene Reports Financial Results for 2013

Marketwired April 30, 2014

Med BioGene (V.MBI) pops 10% on winning regulatory approval on GeneFx(R) Lung

Gaalen Engen March 24, 2014

Med BioGene Announces Regulatory Approval of GeneFx(R) Lung

Marketwired March 24, 2014

Med BioGene Announces Regulatory Approval of GeneFx(R) Lung

Marketwired March 24, 2014

Med BioGene Announces Publication of Data Demonstrating Independent Validation of GeneFx(R) Lung

Marketwired March 7, 2014